Journal of Inherited Metabolic Disease

, Volume 34, Issue 2, pp 261–276

A history of mitochondrial diseases

Mitochondrial Medicine

Abstract

This articles reviews the development of mitochondrial medicine from the premolecular era (1962–1988), when mitochondrial diseases were defined on the basis of clinical examination, muscle biopsy, and biochemical criteria, through the molecular era, when the full complexity of these disorders became evident. In a chronological order, I have followed the introduction of new pathogenic concepts that have shaped a rational genetic classification of these clinically heterogeneous disorders. Thus, mitochondrial DNA (mtDNA)-related diseases can be divided into two main groups: those that impair mitochondrial protein synthesis in toto, and those that affect specific respiratory chain proteins. Mutations in nuclear DNA can affect components of respiratory chain complexes (direct hits) or assembly proteins (indirect hits), but they can also impair mtDNA integrity (multiple mtDNA mutations), replication (mtDNA depletion), or mtDNA translation. Besides these disorders that affect the respiratory chain directly, defects in other mitochondrial functions may also affect oxidative phosphorylation, including problems in mitochondrial protein import, alterations of the inner mitochondrial membrane lipid composition, and defects of mitochondrial dynamics. The enormous and still ongoing progress in our understanding of mitochondrial medicine was made possible by the intense collaboration of an international cadre of “mitochondriacs.” Having published my first paper on a patient with mitochondrial myopathy 37 years ago (DiMauro et al., 1973), I feel qualified to write a history of the mitochondrial diseases, a fascinating, still evolving, and continuously puzzling area of medicine. In each section, I follow a chronological order of the salient discoveries and I show only the portraits of distinguished deceased mitochondriacs and those whose names became eponyms of mitochondrial diseases.

References

  1. Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, Moore A et al (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26:211–215PubMedCrossRefGoogle Scholar
  2. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A et al (2008) OPA1 mutations induce mitochondrial DNA instability and optic atrophy “plus” phenotypes. Brain 131:338–351PubMedCrossRefGoogle Scholar
  3. Antonicka H, Mattman A, Carlson CG, Glerum DM, Hoffbuhr KC, Leary SC et al (2003) Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 72:101–114PubMedCrossRefGoogle Scholar
  4. Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA (2006) The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 15:1835–1846PubMedCrossRefGoogle Scholar
  5. Area-Gomez E, de Groof AJC, Boldogh I, Bird TD, Gibson GE, Koehler CM et al (2009) Presenilins are enriched in mitochondria-associated membranes. Am J Pathol 175:1810–1818PubMedCrossRefGoogle Scholar
  6. Auré K, Benoist JF, de Ogier Baulny H, Romero NB, Rigal O, Lombes A (2004) Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology 63:727–729PubMedGoogle Scholar
  7. Bardosi A, Creutzfeldt W, DiMauro S, Felgenhauer K, Friede RL, Goebel HH et al (1987) Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 74:248–258PubMedCrossRefGoogle Scholar
  8. Barth PG, Scholte HR, Berden JA, Moorsel V, Luyt-Houwen I, Van’t Veer-Korthof ET et al (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62:327–355PubMedCrossRefGoogle Scholar
  9. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D (1996) A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 12:385–389PubMedCrossRefGoogle Scholar
  10. Blass JP, Avigan J, Uhlendorf BW (1970) A defect in pyruvate decarboxylase in a child with an intermittent movement disorder. J Clin Invest 49:423–432PubMedCrossRefGoogle Scholar
  11. Bolender N, Sickmann A, Wagner R, Meisinger C, Pfanner N (2008) Multiple pathways for sorting mitochondrial precursor proteins. EMBO J 9:42–49CrossRefGoogle Scholar
  12. Bonilla E, Sciacco M, Tanji K, Sparaco M, Petruzzella V, Moraes CT (1992) New morphological approaches to the study of mitochondrial encephalomyopathies. Brain Pathol 2:113–119PubMedCrossRefGoogle Scholar
  13. Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwartzenbacher R, Lipton SA (2003) Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 15:706–716PubMedCrossRefGoogle Scholar
  14. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11:144–149PubMedCrossRefGoogle Scholar
  15. Bykhovskaya Y, Casas KA, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308PubMedCrossRefGoogle Scholar
  16. Cao L, Shitara H, Sugimoto M, Hayashi J-I, Abe K, Yonekawa H (2009) New evidence confirms that the mitochondrial bottleneck is generated without reduction of mitochondrial DNA content in early primordial germ cells of mice. PloS Genetics 5(12):e1000756CrossRefGoogle Scholar
  17. Carelli V, Barboni P, Sadun AA (2006) Mitochondrial ophthalmology. In: DiMauro S, Hirano M, Schon EA (eds) Mitochondrial medicine. Informa Healthcare, London, pp 105–142Google Scholar
  18. Chan DC (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:1241–1252PubMedCrossRefGoogle Scholar
  19. Chan DC (2007) Mitochondrial dynamics in disease. New Engl J Med 356:1707–1709PubMedCrossRefGoogle Scholar
  20. Chinnery PF, Taylor DJ, Brown DT, Manners D, Styles P, Lodi R (2000) Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol 47:381–384PubMedCrossRefGoogle Scholar
  21. Chomyn A, Enriquez JA, Micol V, Fernandez-Silva P, Attardi G (2000) The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem 275:19198–19209PubMedCrossRefGoogle Scholar
  22. Cizkova A, Stranecky V, Mayr JA, Tesarova M, Havlikova V, Paul J et al (2009) TMEM70 mutations cause isolated ATP synthase deficiency and eonatal mitochondrial encephalomyopathy. Nat Genet 40:12881290Google Scholar
  23. Coenen MJH, Antonicka H, Ugalde C, Sasarman F, Rossi P, Heister JGAMA et al (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. New Engl J Med 351:2080–2086PubMedCrossRefGoogle Scholar
  24. Cree LM, Samuels DC, de Sousa Lopes SC, Rajasimha HK, Wonnapinij P, Mann JR et al (2008) A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. NatGenet 40:249–254Google Scholar
  25. Darin N, Oldfors A, Moslemi A-R, Holme E, Tulinius M (2001) The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities. Ann Neurol 49:377–383PubMedCrossRefGoogle Scholar
  26. Davey KM, Parboosingh JS, McLeaod DR, Chan A, Casey R, Ferreira P et al (2006) Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-kike condition. J Med Genet 43:385–393PubMedCrossRefGoogle Scholar
  27. De Meirleir L, Seneca S, Lissens W, De Clercq I, Eyskens F, Gerlo E et al (2004) Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J Med Genet 41:120–124PubMedCrossRefGoogle Scholar
  28. DeFrancesco L, Scheffler IE, Bissell MJ (1976) A respiration-deficient Chinese hamster cell line with a defect in NADH-coenzyme Q reductase. J Biol Chem 251:4588–4595PubMedGoogle Scholar
  29. Dejardins P, Frost E, Morais R (1985) Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol Cell Biol 5:1163–1169Google Scholar
  30. Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, Belenguer P et al (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26:207–210PubMedCrossRefGoogle Scholar
  31. DiMauro S, DiMauro-Melis PM (1973) Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182:929–931PubMedCrossRefGoogle Scholar
  32. DiMauro S, Schon EA (2008) Mitochondrial disorders in the nervous system. Annu Rev Neurosci 31:91–123PubMedCrossRefGoogle Scholar
  33. DiMauro S, Hirano M, Schon EA (eds) (2006) Mitochondrial medicine. Informa Healthcare, AbingdonGoogle Scholar
  34. DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC (1985) Mitochondrial myopathies. Ann Neurol 17:521–538PubMedCrossRefGoogle Scholar
  35. DiMauro S, Schotland DL, Bonilla E, Lee CP, Gambetti PL, Rowland LP (1973) Progressive ophthalmoplegia, glycogen storage, and abnormal mitochondria. Arch Neurol 29:170–179PubMedGoogle Scholar
  36. Dimauro S, Bonilla E, Lee CP, Schotland DL, Scarpa A, Conn H et al (1976) Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 27:217–232PubMedCrossRefGoogle Scholar
  37. Diomedi-Camassei F, Di Giandomenico S, Santorelli F, Caridi G, Piemonte F, Montini G et al (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18:2773–2780PubMedCrossRefGoogle Scholar
  38. Dubeau F, De Stefano N, Zifkin BG, Arnold DL, Shoubridge EA (2000) Oxidative phosphorylation defect in the brains of carriers of the tRNAleu (UUR) A3243G mutation in a MELAS pedigree. Ann Neurol 47:179–185PubMedCrossRefGoogle Scholar
  39. Duncan AJ, Bitner-Glindziez M, Meunier B, Costello H, Hargreaves IP, Lopez LC et al (2009) A nonsense mutation in COQ9 causes autosomal recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 84:558–566PubMedCrossRefGoogle Scholar
  40. Edvarson S, Shaag A, Kolesnikova O, Gomori JM, Tarassov I, Einbinder T et al (2007) Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 81:857–862CrossRefGoogle Scholar
  41. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254–260PubMedCrossRefGoogle Scholar
  42. Engel AG, Angelini C (1973) Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 179:899–902PubMedCrossRefGoogle Scholar
  43. Engel WK, Cunningham CG (1963) Rapid examination of muscle tissue: an improved trichrome stain method for fresh-frozen biopsy sections. Neurology 13:919–923PubMedGoogle Scholar
  44. Fenton WA (1995) Mitochondrial protein transport-a system in search of mutations. Am J Hum Genet 57:235–238PubMedGoogle Scholar
  45. Fichera M, Lo Giudice M, Falco M, Sturnio M, Amata A, Calabrese O et al (2004) Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63:1108–1110PubMedGoogle Scholar
  46. Filosto M, Mancuso M, Vives-Bauza C, Vila MR, Shanske S, Hirano M et al (2003) Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Ann Neurol 54:524–526PubMedCrossRefGoogle Scholar
  47. Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T (1980) Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities): disease entity or a syndrome? J Neurol Sci 47:117–133PubMedCrossRefGoogle Scholar
  48. Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BGH, Hans VH et al (2007) The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130:2037–2044PubMedCrossRefGoogle Scholar
  49. Ghezzi D, Goffrini P, Uziel G, Horvath R, Klopstock T, Lochmuller H et al (2009) SDHAF1, encoding a LYR complex II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet 41:654–656PubMedCrossRefGoogle Scholar
  50. Gironi M, Lamperti C, Nemni R, Moggio M, Comi GP, Guerini FR et al (2004) Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology 62:818–820PubMedGoogle Scholar
  51. Gonatas NK, Shy GM (1965) Childhood myopathies with abnormal mitochondria. Proceedings of the Vth International Congress of Neuropathology Vol 100. Excerpta Medica International Congress Series, Amsterdam, pp 606–612Google Scholar
  52. Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651–653PubMedCrossRefGoogle Scholar
  53. Greaves LC, Preston SL, Tadrous PJ, Taylor RW, Barron MJ, Oukrif D, Leedham SJ et al (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by cryptic fission. Proc Natl Acad Sci USA 103:714–719PubMedCrossRefGoogle Scholar
  54. Guan M-X, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P et al (2006) Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12 S ribosomal RNA mutations. Am J Hum Genet 79:291302CrossRefGoogle Scholar
  55. Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma P, Rantamaki M et al (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77:430–441PubMedCrossRefGoogle Scholar
  56. Hansen JJ, Durr A, Cournu-Rebeix I, Georgopoulos C, Ang D, Nyholm Nielsen M et al (2002) Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70(5):1328–1332Google Scholar
  57. Haut S, Brivet M, Tonati G, Rustin P, Lebon S, Garcia-Cazorla A et al (2003) A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum Genet 113:118–122PubMedGoogle Scholar
  58. Haydar NA, Conn HL, Afifi A, Wakid N, Ballas S, Fawaz K (1971) Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria. Ann Int Med 74:548–558PubMedGoogle Scholar
  59. Hers HG (1965) Inborn lysosomal diseases. Gastroenterol 48:625–633Google Scholar
  60. Hinson JT, Fantin VR, Schonberger J, Breivik N, Siem G, McDonough B et al (2007) Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. New Engl J Med 356:809–819PubMedCrossRefGoogle Scholar
  61. Hirano M, Silvestri G, Blake D, Lombes A, Minetti C, Bonilla E et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721–727PubMedGoogle Scholar
  62. Hirano M, Garcia-de-Yebenes J, Jones AC, Nishino I, DiMauro S, Carlo JR et al (1998) Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 63:526–533PubMedCrossRefGoogle Scholar
  63. Hirano M, Marti R, Casali C, Tadesse BS, Uldrick T, Fine B et al (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458–1460PubMedCrossRefGoogle Scholar
  64. Holt IJ, Harding AE, Morgan Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717–719PubMedCrossRefGoogle Scholar
  65. Holt IJ, Harding AE, Petty RK, Morgan Hughes JA (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46:428–433PubMedGoogle Scholar
  66. Horvath R, Hudson G, Ferrari G, Futterer N, Ahola S, Lamantea E et al (2006) Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674–1684PubMedCrossRefGoogle Scholar
  67. Horvath R, Kemp JP, Tuppen HAL, Hudson G, Oldfors A, Marie SKN et al (2009) Molecular basis of infantile reversible cytochrome c oxidase deficiency. Brain 132:3165–3174PubMedCrossRefGoogle Scholar
  68. Hudson G, Keers S, Man PYW, Griffiths P, Huoponen K, Savontaus M-L et al (2005) Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet 77:1086–1091PubMedCrossRefGoogle Scholar
  69. Hudson G, Carelli V, Spruijt L, Gerards M, Mowbray C, Achilli A et al (2007) Clinical expression of leber hereditary optic neuropahy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 81:228–233PubMedCrossRefGoogle Scholar
  70. Hudson G, Amati-Bonneau P, Blakely E, Stewart JD, He L, Schaefer AM et al (2008) Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131:329–337PubMedCrossRefGoogle Scholar
  71. Jacobs HT, Turnbull DM (2005) Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet 21:312–314PubMedCrossRefGoogle Scholar
  72. Jenuth JP, Peterson AC, Fu K, Shoubridge EA (1996) Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA. Nat Genet 14:146–151PubMedCrossRefGoogle Scholar
  73. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y et al (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. New Engl J Med 330:962–968PubMedCrossRefGoogle Scholar
  74. Karadimas CL, Vu TH, Holve SA, Quinzii C, Tanji K, Bonilla E et al (2006) Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 79:544–548PubMedCrossRefGoogle Scholar
  75. Karpati G, Carpenter S, Engel AG (1975) The syndrome of systemic carnitine deficiency. Neurology 25:16–24PubMedGoogle Scholar
  76. Kaufmann P, Shungu D, Sano MC, Jhung S, Engelstad K, Mitsis E et al (2004) Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 62:1297–1302PubMedGoogle Scholar
  77. Kaukonen J, Juselius JK, Tiranti V, Kyttala A, Zeviani M, Comi GP et al (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289:782–785PubMedCrossRefGoogle Scholar
  78. King MP, Attardi G (1989) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500–503PubMedCrossRefGoogle Scholar
  79. King MP, Koga Y, Davidson M, Schon EA (1992) Defects in mitochondrial protein synthesis and respiratory chain activity segragate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Mol Cell Biol 12:480–490PubMedGoogle Scholar
  80. Kirby DM, Salemi R, Sugiana C, Ohtake A, Parry L, Bell KM et al (2004) NUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 114:837–845PubMedGoogle Scholar
  81. Kraytsberg Y, Schwartz M, Brown TA, Ebralidse K, Kunz WS, Clayton DA et al (2004) Recombination of human mitochondrial DNA. Science 304:981PubMedCrossRefGoogle Scholar
  82. Lagier-Tourenne C, Tazir M, Lopez LC, Quinzii C, Assoum M, Drouot N et al (2008) ADSK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661–672PubMedCrossRefGoogle Scholar
  83. Lalani S, Vladutiu GD, Plunkett K, Lotze TE, Adesina AM, Scaglia F (2005) Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch Neurol 62:317–320PubMedCrossRefGoogle Scholar
  84. Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S et al (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60:1206–1208PubMedGoogle Scholar
  85. Ledley FD, Jansen R, Nham SU, Fenton WA, Rosenberg LE (1990) Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes mut0 methylmalonic acidemia. Proc Natl Acad Sci USA 87:3147–3150PubMedCrossRefGoogle Scholar
  86. Lestienne P, Ponsot G (1988) Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1:885PubMedCrossRefGoogle Scholar
  87. Lopez LC, Quinzii C, Schuelke M, Kanki T, Naini A, DiMauro S et al (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaproneyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79:1125–1129PubMedCrossRefGoogle Scholar
  88. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B (1962) A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest 41:1776–1804PubMedCrossRefGoogle Scholar
  89. Magen D, Georgopoulos C, Bross P, Ang D, Segev Y, Goldsher D et al (2008) Mitochondrial Hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 83:30–42PubMedCrossRefGoogle Scholar
  90. Mangiullo R, Gnoni A, Leone A, Gnoni GV, Papa S, Zanotti F (2008) Structural and functional characterization of F0F1-ATP synthase on the extracellular surface of rat hepatocytes. Biochim Biophys Acta 1777:1326–1335PubMedCrossRefGoogle Scholar
  91. Manwaring N, Jones MM, Wang JJ, Rochtchina E, Howard C, Mitchell P et al (2007) Population prevalence of the MELAS A3243G mutation. Mitochondrion 7:230–233PubMedCrossRefGoogle Scholar
  92. Marti R, Nishigaki Y, Hirano M (2003) Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Comm 303:14–18PubMedCrossRefGoogle Scholar
  93. Massa V, Fernandez-Vizarra E, Alshahwan S, Bakhsh E, Goffrini P, Ferrero I et al (2008) Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet. doi:10.1016/j.ajhg.2008.05.002 PubMedGoogle Scholar
  94. Masucci JP, Davidson M, Koga Y, Schon EA, King MP (1995) In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNALys gene: two genotypes produce similar phenotypes. Mol Cell Biol 15:2872–2881PubMedGoogle Scholar
  95. McKenzie M, Lazarou M, Thorburn DR, Ryan MT (2006) Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J Mol Biol 361:462–469PubMedCrossRefGoogle Scholar
  96. Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, Shaag E et al (2004) Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734–738PubMedCrossRefGoogle Scholar
  97. Mollet J, Giurgea I, Schlemmer D, Dallner G, Chretien D, Delahodde A et al (2007) Prenyldiphosphate synthase (PDSS1) and OH-benzoate prenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117:765–772PubMedCrossRefGoogle Scholar
  98. Mollet J, Delahodde A, Serre V, Chretien D, Schlemmer D, Lombes A et al (2008) CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623–630PubMedCrossRefGoogle Scholar
  99. Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M et al (2003) Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 100:605–610PubMedCrossRefGoogle Scholar
  100. Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF et al (1989) Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome `see comments. N Engl J Med 320:1293–1299PubMedCrossRefGoogle Scholar
  101. Moraes CT, Shanske S, Tritschler HJ, Aprille JR, Andreetta F, Bonilla E et al (1991) MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet 48:492–501PubMedGoogle Scholar
  102. Moraes CT, Ricci E, Bonilla E, DiMauro S, Schon EA (1992) The mitochondrial tRNALeu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet 50:934–949PubMedGoogle Scholar
  103. Morais R, Desjardins P, Turmel C, Zinkewich-Peotti K (1988) Development and characterization of continuous avian cell lines depleted of mitochondrial DNA. In Vitro Cell Dev Biol 24:649–658PubMedCrossRefGoogle Scholar
  104. Musumeci O, Naini A, Slonim AE, Scavin N, Hadjigeorgiou GL, Krawiecki N et al (2001) Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56:849–855PubMedGoogle Scholar
  105. Nass MMK, Nass S (1963a) fibers with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol 19:593–612PubMedCrossRefGoogle Scholar
  106. Nass S, Nass M (1963b) Intramitochondrial fibers with DNA characteristics. II. Enzymatic and other hydrolytic treatments. J Cell Biol 19:613–629PubMedCrossRefGoogle Scholar
  107. Naviaux RK, Nguyen KV (2004) POLG mutations associated with Alpers′ syndrome and mitochondrial DNA depletion. Ann Neurol 55:706–712PubMedCrossRefGoogle Scholar
  108. Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC et al (1999) Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers′ syndrome. Ann Neurol 45:54–58PubMedCrossRefGoogle Scholar
  109. Nishigaki Y, Marti RA, Copeland WC, Hirano M (2003) Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111:1913–1921PubMedGoogle Scholar
  110. Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689–692PubMedCrossRefGoogle Scholar
  111. Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86:2379–2382PubMedCrossRefGoogle Scholar
  112. Ogilvie I, Kennaway NG, Shoubridge EA (2005) A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest 115:2784–2792PubMedCrossRefGoogle Scholar
  113. Papadopoulou LC, Sue CM, Davidson MM, Tanji K, Nishino I, Sadlock JE et al (1999) Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene. Nat Genet 23:333–337PubMedCrossRefGoogle Scholar
  114. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16:481–488PubMedCrossRefGoogle Scholar
  115. Petty RK, Harding AE, Morgan Hughes JA (1986) The clinical features of mitochondrial myopathy. Brain 109:915–938PubMedCrossRefGoogle Scholar
  116. Poulton J, Hirano M, Spinazzola A, Arenas Hernandez M, Jardel C, Lombes A et al (2009) Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excludingbthe mitochondrial gamma polymerase, POLG1). Biochim Biophys Acta 1792:1109–1112PubMedGoogle Scholar
  117. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu W-Q et al (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289–293PubMedCrossRefGoogle Scholar
  118. Quinzii C, Kattah AG, Naini A, Akman HO, Mootha VK, DiMauro S et al (2005) Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539–541PubMedCrossRefGoogle Scholar
  119. Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, DiMauro S et al (2006) A mutation in para-Hydoxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78:345–349PubMedCrossRefGoogle Scholar
  120. Ravera S, Panfoli I, Calzia D, Aluigi MG, Bianchini P, Diaspro A et al (2009) Evidence for aerobic ATP synthesis in isolated myelin vesicles. Int J Biochem Cell Biol 41:1581–1591PubMedCrossRefGoogle Scholar
  121. Roesch K, Curran SP, Tranebjaerg L, Koehler CM (2002) Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum Mol Genet 11:477–486PubMedCrossRefGoogle Scholar
  122. Rotig A, Appelkvist E-L, Geromel V, Chretien D, Kadhom N, Edery P et al (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356:391–395PubMedCrossRefGoogle Scholar
  123. Rotig A, Poulton J (2009) Genetic causes of mitochondrial DNA depletion in humans. Biochim Biophys Acta 1792:1103–1108PubMedGoogle Scholar
  124. Rowland LP (1994) Mitochondrial encephalomyopathies: lumping, splitting, and melding. In: Schapira AHV, DiMauro S (eds) Mitochondrial disorders in neurology. Butterworth-Heinemann, Oxford, pp 116–129Google Scholar
  125. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O (2001) Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29:342–344PubMedCrossRefGoogle Scholar
  126. Sacconi S, Salviati L, Nishigaki Y, Walker WF, Hernandez-Rosa E, Trevisson E et al (2008) A functionally dominant mitochondrial DNA mutation. Hum Mol Genet 17:1814–1820PubMedCrossRefGoogle Scholar
  127. Salviati L, Sacconi S, Murer L, Zacchello G, Franceschini L, Laverda AM et al (2005) Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 65:606–608PubMedCrossRefGoogle Scholar
  128. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders-past, present and future. Biochim Biophys Acta 1659:115–120PubMedCrossRefGoogle Scholar
  129. Schaefer AM, McFarland R, Blakely E, Langping H, Whittaker RG, Taylor RW et al (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63(1):35–39Google Scholar
  130. Scheffler IE (1986) Biochemical genetics of respiration-deficient mutants of animal cells. In: Morgan MJ (ed) Carbohydrate metabolism in cultured cells. Plenum, London, pp 77–109Google Scholar
  131. Scheper GC, Klok VD, van Andel RJ, van Berkel CGM, Sissler M, Smet J et al (2007) Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534–538PubMedCrossRefGoogle Scholar
  132. Schlame M, Ren M (2006) Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 580:5450–5455PubMedCrossRefGoogle Scholar
  133. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJJ (2002) Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51:634–637PubMedCrossRefGoogle Scholar
  134. Schwartz F, Vissing J (2004) No evidence of paternal inheritance of mtDNA in patients with sporadic mtDNA mutations. J Neurol Sci 218:99–101PubMedCrossRefGoogle Scholar
  135. Schwartz M, Vissing J (2002) Paternal inheritance of mitohondrial DNA. New Engl J Med 347:576–580PubMedCrossRefGoogle Scholar
  136. Servidei S (2001) Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord 14:107–116Google Scholar
  137. Shankar SP, Fingert JH, Carelli V, Valentino ML, King TM, Daiger SP et al (2008) Evidence for a novel X-linked modifier locus for Leber hereditary optic neuropathy. Opthal Genet 29:17–24CrossRefGoogle Scholar
  138. Shapira Y, Harel S, Russell A (1977) Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci 13:161–164PubMedGoogle Scholar
  139. Shoffner JM, Lott MT, Lezza A, Seibel P, Ballinger SW, Wallace DC (1990) Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61:931–937PubMedCrossRefGoogle Scholar
  140. Shy GM, Gonatas NK (1964) Human myopathy with giant abnormal mitochondria. Science 145:493–496PubMedCrossRefGoogle Scholar
  141. Shy GM, Gonatas NK (1966) Two childhood myopathies with abnormal mitochondria: I. Megaconial myopathy; II. Pleoconial myopathy. Brain 89:133–158PubMedCrossRefGoogle Scholar
  142. Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905–1912PubMedCrossRefGoogle Scholar
  143. Smeitink J, van den Heuvel L (1999) Protein biosynthesis ′99: human mitochondrial complex I in health and disease. Am J Hum Genet 64:1505–1510PubMedCrossRefGoogle Scholar
  144. Smeitink JAM, Elpeleg O, Antonicka H, Diepstra H, Saada A, Smits P et al (2006) Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869–877PubMedCrossRefGoogle Scholar
  145. Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E et al (1997) Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48:1238–1243PubMedGoogle Scholar
  146. Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M et al (2001) Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28:200–201CrossRefGoogle Scholar
  147. Sperl W, Jesina P, Zeman J, Mayr JA, DeMeirleir L, VanCoster R et al (2006) Deficiency of mitochondrial ATP synthase of nuclear origin. Neuromuscul Disord 16:821–829PubMedCrossRefGoogle Scholar
  148. Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S et al (2002) Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128–4132PubMedCrossRefGoogle Scholar
  149. Spinazzola A, Zeviani M (2005) Disorders of nuclear-mitochondrial intergenomic signaling. Gene 354:162–168PubMedCrossRefGoogle Scholar
  150. Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, Dirocco M, Giordano I et al (2009) Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 32:143–158PubMedCrossRefGoogle Scholar
  151. Spiro AJ, Moore CL, Prineas JW, Strasberg PM, Rapin I (1970) A cytochrome-related inherited disorder of the nervous system and muscle. Arch Neurol 23:103–112PubMedGoogle Scholar
  152. Sue CM, Tanji K, Hadjigeorgiou G, Andreu AL, Nishino I, Krishna S et al (1999) Maternally inherited hearing loss in a large kindred with a novel mutation in the mitochondrial DNA tRNASer(UCN) gene. Neurology 52:1905–1908PubMedGoogle Scholar
  153. Takakubo F, Cartwright P, Hoogenraad N, Thorburn DR, Collins F, Lithgow T et al (1995) An amino acid substitution in the pyruvate dehydrogenase E1a gene, affecting mitochondrial import of the precursor protein. Am J Hum Genet 57:772–780PubMedGoogle Scholar
  154. Tanji K, Bonilla E (2001) Optical imaging techniques (histochemical, immunohistochemical, and in situ hybridization staining methods) to visualize mitochondria. Meth Cell Biol 65:311–332CrossRefGoogle Scholar
  155. Tatuch Y, Christodoulou J, Feigenbaum A, Clarke J, Wherret J, Smith C et al (1992) Heteroplasmic mtDNA mutation (T > G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 50:852–858PubMedGoogle Scholar
  156. Taylor RW, Giordano C, Davidson MM, d’Amati G, Bain H, Hayes CM et al (2003a) A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited cardiomyopathy. J Am Coll Cardiol 41:1786–1796CrossRefGoogle Scholar
  157. Taylor RW, McDonnell MT, Blakely EL, Chinnery PF, Taylor GA, Howell N et al (2003b) Genotypes from patients indicate no paternal mitochondrial contribution. Ann Neurol 54:521–524PubMedCrossRefGoogle Scholar
  158. Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M et al (1998) Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63:1609–1621PubMedCrossRefGoogle Scholar
  159. Tiranti V, D'Adamo P, Briem E, Ferrari G, Mineri R, Lamantea E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239–252PubMedCrossRefGoogle Scholar
  160. Tiranti V, Briem E, Lamantea E, Mineri R, Papaleo E, De Gioia L et al (2006) ETHE1 mutations are specific to ethylmalonic encephalopathy. J Med Genet 43:340–346PubMedCrossRefGoogle Scholar
  161. Tiranti V, Visconti C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200–205PubMedCrossRefGoogle Scholar
  162. Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685–1692PubMedCrossRefGoogle Scholar
  163. Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, Donnini C et al (2007) Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EGF1 and EFTu. Am J Hum Genet 80:44–58PubMedCrossRefGoogle Scholar
  164. Valnot I, Osmond S, Gigarel N, Mehaye B, Amiel J, Cormier-Daire V et al (2000a) Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67:1104–1109PubMedGoogle Scholar
  165. Valnot I, von Kleist-Retzow J-C, Barrientos A, Gorbatyuk M, Taanman J-W, Mehaye B et al (2000b) A mutation in the human heme-A:farnesyltransferase gene (COX 10) causes cytochrome c oxidase deficiency. Hum Mol Genet 9:1245–1249PubMedCrossRefGoogle Scholar
  166. Van Goethem G, Dermaut B, Lofgren A, Martin J-J, Van Broeckhoven C (2001) Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28:211–212PubMedCrossRefGoogle Scholar
  167. Van Maldergem L, Trijbels F, DiMauro S, Sindelar PJ, Musumeci O, Janssen A et al (2002) Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 52:750–754PubMedCrossRefGoogle Scholar
  168. Visapaa I, FEellman V, Vesa J, Dasvarma A, Hutton JL, Kumar V et al (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876PubMedCrossRefGoogle Scholar
  169. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ et al (2000) Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Comm 279:378–382PubMedCrossRefGoogle Scholar
  170. Wai T, Teoli D, Shoubridge EA (2010) The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes. Nat Genet 40:1484–1488CrossRefGoogle Scholar
  171. Wallace DC (2005) The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement. Gene 354:169–180PubMedCrossRefGoogle Scholar
  172. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza A et al (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427–1430PubMedCrossRefGoogle Scholar
  173. Willems JL, Monnens L, Trijbels J, Veerkamp JH, Meyer A, van Dam K et al (1977) Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics 60:850–857PubMedGoogle Scholar
  174. Yu Y, Malhotra A, Ren M, Schlame M (2006) The enzymatic function of tafazzin. J Biol Chem 281:39217–39224CrossRefGoogle Scholar
  175. Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S et al (2008) OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 131:352–367PubMedCrossRefGoogle Scholar
  176. Zeviani M, Moraes CT, DiMauro S (1988) Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38:1339–1346PubMedGoogle Scholar
  177. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S (1989) An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309–311PubMedCrossRefGoogle Scholar
  178. Zhu Z, Yao J, Johns T, Fu K, De Bie I, Macmillan C et al (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20:337–343PubMedCrossRefGoogle Scholar
  179. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL et al (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36:449–451PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and Springer 2010

Authors and Affiliations

  1. 1.Department of NeurologyColumbia University Medical CenterNew YorkUSA

Personalised recommendations